US Broker Ratings

iRadimed Corporation (IRMD) Stock Analysis: Exploring Growth Potential in the Medical Devices Sector

iRadimed Corporation (NASDAQ: IRMD), a prominent player in the medical devices industry, has been making notable strides in the healthcare sector with its innovative MRI-compatible products. With a market capitalization..

Savara, Inc. (SVRA) Stock Analysis: Uncovering a 159% Upside Potential in Biotech

Savara, Inc. (NASDAQ: SVRA) presents a compelling opportunity for investors keen on exploring the high-risk, high-reward world of biotechnology. With a market capitalization of $801.19 million, this US-based biopharmaceutical company..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Biotechnology Innovator with 54.40% Potential Upside

Arcus Biosciences, Inc. (NASDAQ: RCUS) stands out in the biotechnology sector with its focus on developing innovative cancer therapies. Headquartered in Hayward, California, the company has carved a niche in..

Zymeworks Inc. (ZYME) Stock Analysis: Exploring a 36% Potential Upside in the Biotech Sector

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company, is making headlines with a compelling potential upside of 36.62%. This potential gain is sparking investor interest, particularly as the company continues..

SI-BONE, Inc. (SIBN) Stock Analysis: Exploring a 63% Potential Upside in the Medical Devices Sector

SI-BONE, Inc. (NASDAQ: SIBN), a prominent player in the healthcare sector’s thriving medical devices industry, has garnered significant attention from investors, not only for its innovative product line but also..

Sionna Therapeutics, Inc. (SION) Stock Analysis: Healthcare Innovator with a 10.47% Potential Upside

Sionna Therapeutics, Inc. (SION), a clinical-stage biopharmaceutical company, is drawing investor attention with its pipeline of promising cystic fibrosis treatments and a notable 10.47% potential upside. Headquartered in Waltham, Massachusetts,..

Xeris Biopharma Holdings, Inc. (XERS): Growth Potential and Analyst Enthusiasm Signal a Promising Investment Opportunity

As a dynamic player in the biotechnology sector, Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) is garnering attention with its innovative approach to treating chronic endocrine and neurological diseases. The company’s..

Akebia Therapeutics (AKBA) Investor Outlook: Exploring a Potential 188% Upside

Akebia Therapeutics, Inc. (NASDAQ: AKBA) stands out in the biopharmaceutical sector with its focus on developing treatments for kidney diseases. The company, headquartered in Cambridge, Massachusetts, has attracted attention from..

Evolus, Inc. (EOLS) Stock Analysis: Exploring a 162% Potential Upside with Strategic Beauty Innovations

Evolus, Inc. (NASDAQ: EOLS) is garnering significant attention in the investment community due to its promising potential upside of 162.30%. As a performance beauty company, Evolus has strategically positioned itself..

Immatics N.V. (IMTX) Stock Analysis: Exploring a Strong Buy Consensus Amidst a Potential 59% Upside

Immatics N.V. (NASDAQ: IMTX), a Germany-based clinical-stage biopharmaceutical company, is capturing investor attention with its promising foray into T cell redirecting immunotherapies aimed at combating cancer. With a market capitalization..

CureVac N.V. (CVAC) Stock Analysis: Navigating the mRNA Frontier with Resilient Potential

CureVac N.V. (NASDAQ: CVAC) emerges as a compelling player on the forefront of biotechnology, leveraging its expertise in messenger ribonucleic acid (mRNA) to pioneer transformative medical treatments. Situated in the..

uniQure N.V. (QURE) Investor Outlook: Biotechnology Innovator with a 157% Upside Potential

For those with a keen eye on the healthcare sector, uniQure N.V. (NASDAQ: QURE) presents a compelling opportunity within the biotechnology industry. With its current stock price at $27.51 and..

Pharvaris N.V. (PHVS) Stock Analysis: Potential 68.99% Upside Beckons Investors

Investors in the biotechnology sector might want to turn their attention to Pharvaris N.V. (NASDAQ: PHVS), a promising player in the healthcare industry with a focus on rare disease therapeutics...

AMN Healthcare Services Inc (AMN): Investor Outlook with a Potential 11.62% Upside in the Healthcare Sector

AMN Healthcare Services Inc (AMN), a prominent player in the healthcare sector, has garnered attention with its comprehensive suite of workforce solutions and staffing services tailored to the needs of..

Niagen Bioscience, Inc. (NAGE): Stock Analysis Reveals 143% Potential Upside Amid Robust Revenue Growth

Niagen Bioscience, Inc. (NAGE), a burgeoning player within the biotechnology sector, is catching the eye of investors with its impressive revenue growth and promising market potential. Based in Los Angeles,..

Ardelyx, Inc. (ARDX) Investor Outlook: A Potential 102.74% Upside in the Biotech Sector

Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology company headquartered in Waltham, Massachusetts, is capturing attention with its promising potential upside of 102.74%. Operating in the healthcare sector, Ardelyx focuses on discovering,..

GH Research PLC (GHRS) Stock Analysis: Exploring a Potential 131.87% Upside in the Biotech Sector

GH Research PLC (NASDAQ: GHRS), a promising player in the biotechnology sector, has captured investor attention with its ambitious focus on developing groundbreaking treatments for depression. Based in Dublin, Ireland,..

Nurix Therapeutics, Inc. (NRIX) Stock Analysis: Biotechnology Innovator with a 113.97% Potential Upside

Nurix Therapeutics, Inc. (NRIX) is capturing the attention of investors, especially with analysts predicting a potential upside of 113.97%. As a clinical-stage biopharmaceutical company, Nurix is focused on the discovery,..

InMode Ltd. (INMD) Stock Analysis: Navigating Growth in the Medical Devices Sector with a 15% Potential Upside

InMode Ltd. (NASDAQ: INMD), a key player in the healthcare sector, is carving a niche in the medical devices industry with its innovative aesthetic solutions. Based in Israel, InMode specializes..

Avadel Pharmaceuticals plc (AVDL) Stock Analysis: Unpacking Growth Potential Amidst Analyst Consensus

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a compelling player in the healthcare sector, specifically within the drug manufacturing industry, with a focus on specialty and generic formulations. Headquartered in Dublin,..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds